PortfoliosLab logoPortfoliosLab logo
NEM vs. CME
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NEM vs. CME - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Newmont Corporation (NEM) and CME Group Inc. (CME). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NEM achieves a 0.82% return, which is significantly lower than CME's 1.58% return. Over the past 10 years, NEM has underperformed CME with an annualized return of 13.80%, while CME has yielded a comparatively higher 15.38% annualized return.


NEM

1D
2.71%
1M
-15.55%
YTD
0.82%
6M
2.58%
1Y
81.14%
3Y*
36.14%
5Y*
10.51%
10Y*
13.80%

CME

1D
2.80%
1M
-8.82%
YTD
1.58%
6M
1.41%
1Y
3.34%
3Y*
19.92%
5Y*
9.17%
10Y*
15.38%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NEM vs. CME - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NEM
Newmont Corporation
0.82%172.82%-7.83%-8.76%-20.77%7.40%40.28%30.52%-6.15%10.91%
CME
CME Group Inc.
1.58%19.83%15.41%31.32%-22.89%29.47%-6.34%9.67%32.15%32.35%

Correlation

The correlation between NEM and CME is -0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.09

Correlation (3Y)
Calculated over the trailing 3-year period

0.00

Correlation (5Y)
Calculated over the trailing 5-year period

0.09

Correlation (10Y)
Calculated over the trailing 10-year period

0.08

Correlation (All Time)
Calculated using the full available price history since Dec 6, 2002

0.12

The correlation between NEM and CME shifts across timeframes, from -0.09 (1 year) to 0.12 (all time), reflecting how their relationship changes across market environments.

Fundamentals

EPS

NEM:

$6.34

CME:

$11.75

PE Ratio

NEM:

15.82

CME:

22.94

PEG Ratio

NEM:

0.41

CME:

2.00

PS Ratio

NEM:

4.83

CME:

14.40

Total Revenue (TTM)

NEM:

$17.23B

CME:

$6.76B

Gross Profit (TTM)

NEM:

$8.97B

CME:

$5.84B

EBITDA (TTM)

NEM:

$13.78B

CME:

$5.69B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NEM vs. CME — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NEM
NEM Risk / Return Rank: 8282
Overall Rank
NEM Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
NEM Sortino Ratio Rank: 7878
Sortino Ratio Rank
NEM Omega Ratio Rank: 8080
Omega Ratio Rank
NEM Calmar Ratio Rank: 8282
Calmar Ratio Rank
NEM Martin Ratio Rank: 8484
Martin Ratio Rank

CME
CME Risk / Return Rank: 4545
Overall Rank
CME Sharpe Ratio Rank: 4949
Sharpe Ratio Rank
CME Sortino Ratio Rank: 4040
Sortino Ratio Rank
CME Omega Ratio Rank: 4040
Omega Ratio Rank
CME Calmar Ratio Rank: 4646
Calmar Ratio Rank
CME Martin Ratio Rank: 4848
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NEM vs. CME - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Newmont Corporation (NEM) and CME Group Inc. (CME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NEMCMEDifference
Sharpe ratioReturn per unit of total volatility

+1.57

Sortino ratioReturn per unit of downside risk

+1.72

Omega ratioGain probability vs. loss probability

1.29

1.05

+0.25

Calmar ratioReturn relative to maximum drawdown

2.78

0.16

+2.62

Martin ratioReturn relative to average drawdown

7.58

0.50

+7.08

NEM vs. CME - Sharpe Ratio Comparison

The current NEM Sharpe Ratio is 1.73, which is higher than the CME Sharpe Ratio of 0.16. The chart below compares the historical Sharpe Ratios of NEM and CME, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NEM vs. CME - Drawdown Comparison

The maximum NEM drawdown since its inception was -81.30%, roughly equal to the maximum CME drawdown of -77.50%. Use the drawdown chart below to compare losses from any high point for NEM and CME.


Loading charts...

Drawdown Indicators


NEMCMEDifference

Max Drawdown

Largest peak-to-trough decline

-81.30%

-77.50%

-3.80%

Max Drawdown (1Y)

Largest decline over 1 year

-29.39%

-21.42%

-7.97%

Max Drawdown (3Y)

Largest decline over 3 years

-36.57%

-21.42%

-15.15%

Max Drawdown (5Y)

Largest decline over 5 years

-62.40%

-31.74%

-30.66%

Max Drawdown (10Y)

Largest decline over 10 years

-62.40%

-37.36%

-25.04%

Current Drawdown

Current decline from peak

-23.71%

-15.03%

-8.68%

Average Drawdown

Average peak-to-trough decline

-41.37%

-20.68%

-20.69%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.73%

6.70%

+4.03%

Volatility

NEM vs. CME - Volatility Comparison

Newmont Corporation (NEM) has a higher volatility of 15.74% compared to CME Group Inc. (CME) at 10.45%. This indicates that NEM's price experiences larger fluctuations and is considered to be riskier than CME based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NEMCMEDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.74%

10.45%

+5.29%

Volatility (6M)

Calculated over the trailing 6-month period

37.43%

17.44%

+19.99%

Volatility (1Y)

Calculated over the trailing 1-year period

47.44%

20.74%

+26.70%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

37.99%

20.15%

+17.84%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.67%

23.93%

+11.74%

Dividends

NEM vs. CME - Dividend Comparison

NEM's dividend yield for the trailing twelve months is around 1.02%, less than CME's 4.17% yield.


PositionTTM20252024202320222021202020192018201720162015
CME
CME Group Inc.
4.17%1.83%4.48%4.58%5.05%3.00%3.24%2.74%2.42%4.20%4.90%5.41%
NEM
Newmont Corporation
1.02%1.00%2.69%3.87%4.66%3.55%1.74%3.31%1.62%0.67%0.37%0.56%

Financials

NEM vs. CME - Financials Comparison

This section allows you to compare key financial metrics between Newmont Corporation and CME Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B6.00B7.00B202220232024202520260
1.88B
(NEM) Total Revenue
(CME) Total Revenue
Values in USD except per share items

Frequently Asked Questions


NEM and CME have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NEM has higher volatility (15.74%) compared to CME (10.45%). In terms of maximum drawdown, NEM dropped -81.30% vs CME's -77.50%.

NEM currently has the higher Sharpe Ratio (1.73 vs 0.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NEM and CME

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer